Pathology depth
TURBT pathology should clarify grade, lamina propria invasion, muscle presence and muscle invasion.
A urologic-oncology review for bladder cancer, organized around pathology, muscle-invasive or metastatic status, TURBT/cystectomy history, kidney function, urinary obstruction and prior systemic or intravesical therapy.
Bladder cancer review depends on whether the disease is non-muscle invasive, muscle invasive, post-cystectomy recurrent or metastatic. Variant histology and kidney function can change the clinical question.
The file is organized so the specialist can see the TURBT findings, cystoscopy history, pathology depth, imaging stage and whether urinary obstruction or kidney impairment is present.
TURBT pathology should clarify grade, lamina propria invasion, muscle presence and muscle invasion.
Urothelial carcinoma and variant histologies are documented.
Bladder/pelvic extension, lymph nodes, lung, liver or bone disease are summarized.
BCG/intravesical therapy, TURBTs, cystectomy, radiation and complications are listed.
Cisplatin/gemcitabine, immunotherapy, antibody-drug conjugates or other therapies are organized.
Hydronephrosis, nephrostomy/stent, creatinine/eGFR, bleeding and infections are documented.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Whether muscle was present in TURBT pathology affects confidence in staging.
Kidney function affects systemic therapy interpretation and travel safety.
Hydronephrosis or recurrent infection can make timing urgent.
Non-muscle invasive recurrence and metastatic disease require very different routing.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
The review checks whether the file supports the stated stage.
Urinary obstruction and infection are not treated as secondary details.
CHA coordinates records and communication; physicians decide suitability.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.